Ferozsons Laboratories Limited (PSX: FEROZ)

Ferozsons Laboratories Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	2,179	551.06	569.05	415.83	830.51	151.39
Short-Term Investments	490.66	-	-	-	-	-
Trading Asset Securities	434.67	496.5	544.97	2,036	1,940	760.71
Cash & Short-Term Investments	3,104	1,048	1,114	2,452	2,771	912.1
Cash Growth	135.36%	-5.97%	-54.57%	-11.51%	203.80%	-19.48%
Accounts Receivable	3,118	2,417	1,123	1,140	1,540	1,093
Other Receivables	255.86	283.81	259.9	432.11	23.37	39.27
Receivables	3,374	2,700	1,383	1,572	1,563	1,132
Inventory	4,901	4,978	5,196	3,260	2,107	2,116
Prepaid Expenses	-	11.84	7.05	1.15	0.42	0.92
Other Current Assets	846.07	1,046	833	468.26	629.81	716.87
Total Current Assets	12,225	9,783	8,533	7,754	7,071	4,877
Property, Plant & Equipment	11,765	11,828	7,975	6,113	4,792	3,996
Other Intangible Assets	36.66	41.04	1.55	1	0.64	0.42
Other Long-Term Assets	100.52	96.98	93.92	93.92	93.92	93.71
Total Assets	24,127	21,750	16,603	13,962	11,958	8,967
Accounts Payable	2,689	1,125	2,716	1,657	1,354	998.52
Accrued Expenses	178.39	897.6	539.82	611.89	615.99	371.47
Short-Term Debt	2,826	2,743	1,261	492.52	-	51.02
Current Portion of Long-Term Debt	352.62	333.07	379.88	141.69	181.53	28.32
Current Unearned Revenue	530.45	471.27	251.96	200.95	79.89	34.72
Other Current Liabilities	1,748	514.79	343.17	282.76	287.6	309.02
Total Current Liabilities	8,325	6,085	5,491	3,387	2,519	1,793
Long-Term Debt	1,828	1,844	1,841	1,537	957.1	95.07
Long-Term Unearned Revenue	443.54	476.91	531.88	331.33	174.13	4.68
Long-Term Deferred Tax Liabilities	1,469	1,524	375.36	408.64	415.23	426.23
Total Liabilities	12,065	9,929	8,240	5,664	4,066	2,319
Common Stock	434.69	434.69	434.69	362.24	362.24	301.87
Retained Earnings	7,314	7,040	6,290	6,100	5,713	4,645
Comprehensive Income & Other	3,700	3,754	1,193	1,305	1,398	1,474
Total Common Equity	11,449	11,228	7,918	7,768	7,473	6,421
Minority Interest	612.5	591.88	445.45	530.68	419.17	227.89
Shareholders' Equity	12,061	11,820	8,364	8,298	7,892	6,648
Total Liabilities & Equity	24,127	21,750	16,603	13,962	11,958	8,967
Total Debt	5,007	4,920	3,482	2,171	1,139	174.41
Net Cash (Debt)	-1,903	-3,872	-2,368	280.9	1,632	737.7
Net Cash Growth	-	-	-	-82.79%	121.28%	-33.70%
Net Cash Per Share	-43.77	-89.08	-54.47	6.46	37.55	16.97
Filing Date Shares Outstanding	43.47	43.47	43.47	43.47	43.47	43.47
Total Common Shares Outstanding	43.47	43.47	43.47	43.47	43.47	43.47
Working Capital	3,899	3,698	3,042	4,367	4,552	3,084
Book Value Per Share	263.38	258.31	182.16	178.70	171.92	147.70
Tangible Book Value	11,412	11,187	7,917	7,767	7,473	6,420
Tangible Book Value Per Share	262.53	257.36	182.12	178.67	171.91	147.69
Land	-	1,691	849.15	849.15	849.15	849.15
Buildings	-	2,013	1,117	1,048	1,028	1,014
Machinery	-	5,077	3,363	2,980	2,660	2,470
Construction In Progress	3,714	3,708	4,160	2,337	1,011	97.46

Source: S&P Capital IQ. Standard template. Financial Sources.